<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>OAR@UM Community:</title>
    <link>https://www.um.edu.mt/library/oar/handle/123456789/430</link>
    <description />
    <pubDate>Sun, 21 Jun 2026 08:56:01 GMT</pubDate>
    <dc:date>2026-06-21T08:56:01Z</dc:date>
    <item>
      <title>Endotoxin exposure associated with respiratory health among European schoolchildren : the SINPHONIE study</title>
      <link>https://www.um.edu.mt/library/oar/handle/123456789/147462</link>
      <description>Title: Endotoxin exposure associated with respiratory health among European schoolchildren : the SINPHONIE study
Authors: Baloch, Ramen Munir; Magyar, Donát; Rudnai, Peter; Pándics, Tamás; Remény-Nagy, Zsuzsanna; Moshammer, Hanns; Leppänen, Hanna; Hyvärinen, Anne; Täubel, Martin; Norbäck, Dan; Gabriel, Marta; Maio, Sara; Baldacci, Sandra; Sarno, Giuseppe; Viegi, Giovanni; Csobod, Eva; de Oliveira Fernandesi, Eduardo; Annesi-Maesano, Isabella; Szuppinger, Péter; Prokai, Réka; Farkas, Petur; Fuzi, Cecilia; Cani, Eduart; Draganic, Jasna; Réka Mogyorosy, Eszter; Korac, Zorica; Ventura, Gabriela; Madureira, Joana; Paciência, Inês; Martins, Anabela; Pereira, Ricardo; Ramos, Elisabete; Páldy, Anna; Dura, Gyula; Beregszászi, Tímea; Vaskövi, Éva; Magyar, Donát; Pándics, Tamás; Remény-Nagy, Zsuzsanna; Szentmihályi, Renáta; Udvardy, Orsolya; Varró, Mihály J.; Kephalopoulos, Stylianos; Kotzias, Dimitrios; Barrero-Moreno, Josefa; Mehmeti, Rahmije; Vilic, Aida; Maestro, Daniel; Hohenblum, Philipp; Goelen, Eddy; Stranger, Marianne; Spruy, Maarten; Sidjimov, Momchil; Hadjipanayis, Adamos; Katsonouri-Sazeides, Andromachi; Demetriou, Eleni; Kubinova, Ruzana; Kazmarová, Helena; Dlouha, Beatricia; Kotlík, Bohumil; Vabar, Helen; Ruut, Juri; Metus, Meelis; Rand, Kristiina; Järviste, Antonina; Nevalainen, Aino; Hyvarinen, Anne; Täubel, Martin; Järvi, Kati; Mandin, Corinne; Berthineau, Bruno; Moriske, Heinz-Joern; Giacomini, Marcia; Neumann, Anett; Bartzis, John; Kalimeri, Krystallia; Saraga, Dikaia; Santamouris, Mattheos; Assimakopoulos, Niki; Asimakopoulos, Vasiliki; Cattaneo, Andrea; Pulvirenti, Salvatore; Vercelli, Franco; Strangi, Fabio; Omeri, Elida; Piazza, Silvia; D’Alcamo, Andrea; Fanetti, Anna Clara; Sestini, Piersante; Kouri, Magdalini; Viegi, Giovanni; Sarno, Giuseppe; Baldacci, Sandra; Maio, Sara; Cerrai, Sonia; Franzitta, Vincenzo; Bucchieri, Salvatore; Cibella, Fabio; Simoni, Marzia; Maugeri, Salvatore; Neri, Margherita; Martuzevičius, Dainius; Krugly, Edvinas; Montefort, Stephen; Fsadni, Peter; Brewczyński, Piotr Z.; Krakowiak, Ewa; Kurek, Jolanta; Kubarek, Elżbieta; Wlazło, Agnieszka; Borrego, Carlos; Alves, Célia; Valente, Joana; Gurzau, Eugen; Rosu, Cristina; Popita, Gabriela; Neamtiu, Iulia; Neagu, Cristina; Norback, Dan; Bohms, Michel; Van Den Hazel, Peter; Cassee, Flemming; de Bruin, Yuri Bruinen; Bartonova, Alena; Yang, Aileen; Halzlová, Katarína; Jajcaj, Michal; Kániková, Milada; Miklankova, Olga; Vítkivá, Marianna; Jovasević-Stojanovic, Milena; Zivkovic, Marija; Stevanovic, Zarko; Lazovic, Ivan; Stevanovic, Zana; Zivkovic, Zorica; Cerovic, Sofija; Jocic- Stojanovic, Jasmina; Mumovic, Dejan; Tarttelin, Paula; Chatzidiakou, Lia; Chatzidiakou, Evangelia
Abstract: Background: Evidence on the association between endotoxin exposure and respiratory&#xD;
health in children remains inconsistent, with limited research addressing school environments—&#xD;
key settings for daily exposure. This study investigates the relationship&#xD;
between classroom endotoxin levels and respiratory health among European&#xD;
schoolchildren.; Methods: Within the EU-funded SINPHONIE project, endotoxin concentrations were&#xD;
measured in 285 classrooms across 102 schools in 22 European countries. A total of&#xD;
5,140 children completed a standardized health questionnaire; 4,633 had endotoxin&#xD;
data, 4,170 performed spirometry, and 746 underwent fractioned exhaled nitric oxide&#xD;
(FeNO) testing.; Findings: Endotoxin levels varied geographically, with the highest averages in Italy and&#xD;
the lowest in Finland. After adjusting for confounders, exposure to endotoxin levels at or&#xD;
above the median was associated with higher odds of upper and lower respiratory&#xD;
symptoms—runny nose, nasal obstruction, cough, dry throat, breathing difficulty, and&#xD;
feverishness—as well as reduced lung function (p &lt; 0.05). Meta-analysis by WHO&#xD;
European clusters confirmed these associations, though region-specific analyses indicated&#xD;
a possible protective effect of endotoxin exposure in Northern Europe.; Interpretation: Findings from SINPHONIE highlight classroom endotoxin as a potential&#xD;
environmental determinant of respiratory health. Reducing exposure in schools—currently&#xD;
an overlooked setting—may support respiratory well-being in children and inform&#xD;
future public health policies.</description>
      <pubDate>Wed, 01 Jan 2025 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.um.edu.mt/library/oar/handle/123456789/147462</guid>
      <dc:date>2025-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Mortality and recurrence following surgically treated primary lung malignancy</title>
      <link>https://www.um.edu.mt/library/oar/handle/123456789/147438</link>
      <description>Title: Mortality and recurrence following surgically treated primary lung malignancy
Abstract: Primary lung malignancy comprised 10.3% of all new cancers detected in Malta in 2020.&#xD;
Our study examines patient outcomes and mortality rates following surgically resected&#xD;
primary lung malignancy.; We retrospectively analysed the electronic records of 126 patients who underwent surgical&#xD;
resection of their primary lung malignancy between 2016 and 2020.; Our study included 126 patients with an average age of 66.4 years and 64.3% were male&#xD;
(n=81). 71 .4% of patients underwent lobectomy (n=90). The median time from date of&#xD;
histological diagnosis to date of resection was 51 days. Adenocarcinoma was the&#xD;
commonest histological diagnosis (71.4%, n=90). Pre-operative radiological staging&#xD;
underestimated the tumour's stage in 27.0% (n=34) of cases. A majority had Stage IA&#xD;
disease (51.6%, n=65) according to TNM Classification 8th Edition, and these patients had&#xD;
the best 2-year survival at 96.9% (n=63). Overall survival was 87.3% at two years. At the&#xD;
time of data analysis 26.2% of patients (n=33) had died. Most commonly, death was&#xD;
attributed to progression of malignancy (57 .6%, n=19). Our study identified recurrent&#xD;
disease in 40.5% (n=51) of patients, with a progression free survival (PFS) of 34.4 months.&#xD;
70.6% (n=24) of wedge resections were carried out in Stage IA disease. PFS was 49.5&#xD;
months for lobectomy vs 48.9 months for wedge resections of Stage IA disease. 28.6%&#xD;
(n=36) of patients had a second malignancy, with the most common being colorectal&#xD;
(22.2%, n=8).; Our results correlate well with international data regarding survival and outcomes postlobectomy&#xD;
and limited resection in Stage IA disease. There is limited data regarding the&#xD;
incidence of other primary tumours in patients with early-stage lung cancer.</description>
      <pubDate>Sun, 01 Jan 2023 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.um.edu.mt/library/oar/handle/123456789/147438</guid>
      <dc:date>2023-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>A Maltese study in determining the presence of chronic obstructive pulmonary disease in metabolic syndrome</title>
      <link>https://www.um.edu.mt/library/oar/handle/123456789/147437</link>
      <description>Title: A Maltese study in determining the presence of chronic obstructive pulmonary disease in metabolic syndrome
Authors: Gauci, Jonathan; Gauci Pullicino, Stephanie; Caruana, Emma; Petroni Magri, Vanessa; Formosa, Melissa Marie; Fenech, Anthony G.; Fava, Stephen; Montefort, Stephen; Fsadni, Peter
Abstract: Introduction: Both Chronic Obstructive Pulmonary Disease (COPD) and Metabolic Syndrome (MetS) are pro-inflammatory states,&#xD;
and while the diagnosis of MetS in COPD has been extensively studied, the diagnosis of COPD in MetS is poorly studied. The study&#xD;
focuses on determining the presence of COPD in persons living with diabetes and MetS in Malta, and aims to identify differences in&#xD;
biomarkers between MetS subjects with and without COPD.; Materials and Methods: Diabetic MetS subjects at Malta’s main general hospital were assessed through St George’s Respiratory&#xD;
Questionnaire for COPD (SGRQ-C), modified Medical Research Council scale (mMRC), COPD Assessment Test (CAT), Centre for&#xD;
Epidemiological Studies Depression scale (CES-D), Functional Assessment of Chronic Illness Therapy (FACIT) Fatigue scale,&#xD;
Spirometry, Six Minute Walk Test (6MWT), BODE index (composed of Body Mass Index, Obstruction, Dyspnoea, Exercise capacity)&#xD;
and routine blood tests. They were divided into three groups: the main study group consisted of MetS subjects with COPD, one control&#xD;
group consisted of MetS subjects with a smoking history but not COPD, and the other control group consisted of diabetic MetS&#xD;
subjects with no smoking history.; Results: A total of 67 MetS subjects were included. Those with COPD had significantly worse outcomes in SGRQ-C scores, mMRC,&#xD;
CAT, spirometry, BODE, CES-D and FACIT Fatigue scale than smokers without COPD and non-smokers. 25-hydroxy-vitamin&#xD;
D levels were significantly lower in MetS subjects with COPD compared to smokers without COPD (p=0.030) and non-smokers&#xD;
(p=0.043). C-reactive protein (p=0.036), triglycerides (p=0.023) and total cholesterol (p=0.039) were significantly higher in MetS&#xD;
subjects with COPD compared to smokers without COPD.; Discussion: Screening for depression and fatigue in subjects with COPD and MetS is recommended. Low vitamin D, high CRP, high&#xD;
triglyceride and high total cholesterol levels are correlated with a COPD diagnosis within the local MetS population, and monitoring&#xD;
these parameters would enable timely management.</description>
      <pubDate>Thu, 01 Jan 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.um.edu.mt/library/oar/handle/123456789/147437</guid>
      <dc:date>2026-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Radiological manifestations of lymphangioleiomyomatosis : a local patient cohort analysis</title>
      <link>https://www.um.edu.mt/library/oar/handle/123456789/147436</link>
      <description>Title: Radiological manifestations of lymphangioleiomyomatosis : a local patient cohort analysis
Authors: Conti, Luca; Mercieca, Darlene; Gatt, Gianluca; Sant Fournier, Luca; Fsadni, Peter
Abstract: Background: Lymphangioleiomyomatosis (LAM) is an ultra-rare neoplastic cystic disease primarily affecting&#xD;
females of reproductive age, characterized by the infiltration of smooth muscle cells into the lungs and the&#xD;
formation of cystic lesions. This study aims to compare the radiological findings in patients with sporadic&#xD;
LAM (s-LAM) and those with LAM associated with tuberous sclerosis complex (TSC-LAM) in the Maltese&#xD;
population.; Methods: A retrospective observational study was conducted at Mater Dei Hospital, Malta, involving eight&#xD;
patients diagnosed with LAM between 2014 and 2024. Thoracic and abdominal CT scans were reviewed, and&#xD;
findings were categorized based on the presence of s-LAM or TSC-LAM.; Results: The cohort included five patients with s-LAM and three with TSC-LAM, alongside 15 patients with&#xD;
tuberous sclerosis complex (TSC) but no LAM. All LAM patients exhibited diffuse thin-walled cysts, with&#xD;
sizes ranging from 7 to 72 mm. Notably, chylous pleural effusions were observed only in the s-LAM group.&#xD;
The TSC-LAM group demonstrated significant extra-pulmonary manifestations, including renal&#xD;
angiomyolipomas, with some requiring intervention.; Conclusion: This study highlights the distinct radiological features and complications associated with s-LAM&#xD;
and TSC-LAM. The findings underscore the necessity for vigilant screening and monitoring in TSC patients&#xD;
to manage potential LAM-related complications effectively. A multidisciplinary approach is essential for&#xD;
optimizing patient outcomes and addressing the broader implications of TSC and LAM on health.</description>
      <pubDate>Wed, 01 Jan 2025 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.um.edu.mt/library/oar/handle/123456789/147436</guid>
      <dc:date>2025-01-01T00:00:00Z</dc:date>
    </item>
  </channel>
</rss>

